China Pharma Holdings, Inc. (CPHI) stock
CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
$0.54−0.01 (-1.43%)
Close on Nov 11, 2026Market cap $23.37MP/E –Yield –
China Pharma total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
China Pharma's total debt was $1.64M at Jun 30, 2026. For fiscal 2025 it was $1.44M, up 25.3% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.44M | +25.3% |
| FY2024 | Dec 31, 2024 | $1.14M | +1.0% |
| FY2023 | Dec 31, 2023 | $1.13M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.64M | +16.9% |
| Q1 FY2026 | Mar 31, 2026 | $1.47M | +27.1% |
| Q4 FY2025 | Dec 31, 2025 | $1.44M | +25.3% |
| Q3 FY2025 | Sep 30, 2025 | $1.41M | +24.7% |
| Q2 FY2025 | Jun 30, 2025 | $1.41M | – |
| Q1 FY2025 | Mar 31, 2025 | $1.15M | – |
| Q4 FY2024 | Dec 31, 2024 | $1.14M | – |
| Q4 FY2023 | Dec 31, 2023 | $1.13M | – |
See a number that looks wrong?